No disclosures for any of the speakers!
|
|
- Margery Booker
- 5 years ago
- Views:
Transcription
1 Opiate Use Disorders and Pain in the elderly: Integrating care with the pain specialist Gabriel Paulian M.D Christopher Ong, M.D Yuliet Sanchez, M.D Uma Suryadevara, M.D No disclosures for any of the speakers! 1
2 Where s the pain? 2
3 Algorithm for a general approach to the assessment of chronic nonmalignant pain ROBERT P. JACKMAN, MD, JANEY M. PURVIS, MD, Cascades East Family Medicine Residency Program, Oregon Health and Science University, Klamath Falls, Oregon BARBARA S. MALLETT, MD, Spinal Diagnostics, Tualatin, Oregon Am Fam Physician Nov 15;78(10): WHO Step Ladder Approach 3
4 4
5 Are opiates indicated in my patient? Influences on therapeutic decisions: Outcomes during prior therapies Pain severity and course Age and medical comorbidities Reasonable alternatives Likelihood of addiction/abuse/diversion If they are indicated: what are the possible outcomes Critical outcomes Pain relief Function - physical and psychosocial Side effects Drug-related behaviors: abuse, addiction, pseudoaddiction, diversion 5
6 Barriers to Opioid Therapy Patient-related factors Fear of addiction System factors Availability in pharmacies Clinician-related factors Poor knowledge of pain management, opioid pharmacology and chemical dependency Fear of regulatory oversight 6
7 Opioid Therapy: what are my options? Immediate-release preparations Used mainly : opioid naïve patients acute pain dose finding during initial treatment of chronic pain rescue dosing (breakthrough pain ) Can be used for long-term management in select patients Opioid Therapy: what else do I need to know? Dose limit? Duration of opioid therapy lifetime? Tolerance Hyperalgesia 7
8 Opioid Therapy: Side Effects Common Constipation Somnolence, mental clouding Less common Nausea Myoclonus Pruritus Urinary retention -Sweating -Amenorrhea -Sexual dysfunction -Headache Opioid Therapy Scenario 1: 67 y/o F with PMHx of chronic knee pain secondary to severe DJD managed with OXYCODONE/APAP 5/325 1 tab po QID 8
9 9
10 Opioid Therapy Scenario 2: 72 y/o M with PMHx of low back pain secondary to failed back surgery managed with METHADONE 10 mg po Q 8 hrs Opioid Therapy 10
11 11
12 Psychiatric Comorbidities Depression is present in more than 50% of patients with chronic pain. Severity of pain is a strong predictor of worsening depression and health-related quality of life outcomes. Treatment options in the context of pain: Medications (SSRIs, anxiolytics, TCAs), CBT, Complementary and alternative treatment, Lifestyle changes Psychiatric Comorbidities: Depression Chronic pain is an important risk factor for suicide. Suicide Risk assessment tools in patients with pain. Consider other treatment options if patient is at a higher risk for suicide or depression: A delicate balance! 12
13 Psychiatric comorbidities: Anxiety Treatment in the context of pain: Antidepressants (SNRIs, TCAs) psychological treatments, other anxiolytics. Benzodiazepines: The main actions are hypnotic, anxiolytic, anticonvulsant, myorelaxant, and amnesic. Adverse effects in elderly from Benzodiazepines: psychomotor impairment, occasionally paradoxical excitement, falls and fractures, intellectual and cognitive impairment. Some Important Data: 2004 to 2008: 111% increase in the estimated number of emergency department visits involving nonmedical use of opioid analgesics to 2008: 89% increase in such visits for benzodiazepines. From : Opioid prescribing rates increased 32 percent data: Opioid analgesics were involved in 75% of pharmaceutical overdose deaths. cdc.gov 13
14 Benzodiazepines Data from the National Vital Statistics System multiple cause-of-death file: Benzodiazepines were involved in 31% of opioid-analgesic poisoning deaths in 2011, up from 13% in Prescribing Benzodiazepines with Opiates is DANGEROUS! Alternatives for Benzodiazepines Pain Substance Use Disorders: Another Comorbidity Chronic pain Physical dependence Tolerance Addiction Pseudoaddiction Hyperalgesia Opioid induced hyperalgesia 14
15 Addiction Substance Use Disorder Chronic pain and depression can predispose to benzo abuse and dependence Risk increases with age and more common among patients on multiple medications Commonly used questionnaires are less sensitive in the elderly Opioid Use screening tools SOAPP (Screener and Opioid Assessment for Patients with Pain-Revised) ORT (Opioid Risk Tool) DIRE (Diagnosis, Intractability, Risk, Efficacy Tool) SISAP (Screening Instrument for Substance Abuse Potential) 15
16 Ongoing assessment tools: COMM (Current Opioid Misuse Measure) ABC (Addiction Behaviors Checklist) Chabal 5-Point Checklist PMQ (Pain Medication Questionnaire) PDUQ (Prescription Drug Use Questionnaire) PADT (Pain Assessment and Documentation Tool) Working together Treatment options like CBT, Relaxation therapy and group therapy. Treat pain and psychiatric comorbidities together. Multidisciplinary treatment approach: best approach for pain management. 16
Nociceptive Pain. Pathophysiologic Pain. Types of Pain. At Presentation. At Presentation. Nonpharmacologic Therapy. Modulation
Learning Objectives Effective, Safe Analgesia An Approach to Appropriate Outpatient Chronic Pain Treatment By the end of this presentation, participants will be able to: Identify multiple factors that
More informationMedication Use & Chronic Pain Control: Managing Tolerance, Dependence, Addiction & Aberrant Medication Taking Behavior
Medication Use & Chronic Pain Control: Managing Tolerance, Dependence, Addiction & Aberrant Medication Taking Behavior Ernest J Dole, PharmD, PhC, FASHP, BCPS, CDE Pharmaceutical Care Coordinator ABQ Health
More informationMedical vs. Use of Drugs. Warning Signs of Chemical Dependence. Intent Effect. Legality Pattern 5/5/2010. Daily use above ceiling doses
Identifying and Preventing Drug Abuse By: Lon R. Hays, M.D., M.B.A. Professor and Chairman Department of Psychiatry University of Kentucky Healthcare Medical vs. Non-Medical Use of Drugs Intent Effect
More informationGilberto Gerra. Drug Prevention and Health Branch
Operational Recommendations on ensuring the availability of and access to controlled substances exclusively for medical and scientific purposes, while preventing their diversion Gilberto Gerra Drug Prevention
More informationOpioids: Use and Misuse/Steven Feinberg, MD; Scott Levy, MD, MPH, FACOEM
Western Occupational Health Conference September 14, 2012 Opioid - Use & Misuse Scott Levy, MD MPH FACOEM Steven Feinberg, MD, MPH Disclosure Information Western Occupational Health Conference 2012 Steven
More informationQuality ID #414: Evaluation or Interview for Risk of Opioid Misuse National Quality Strategy Domain: Effective Clinical Care
Quality ID #414: Evaluation or Interview for Risk of Opioid Misuse National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION:
More informationSHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR ALCOHOL DEPENDENCE INDICATION
SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR ALCOHOL DEPENDENCE INDICATION Naltrexone is used as part of a comprehensive programme of treatment against alcoholism to reduce the
More informationResponding to The Joint Commission Alert on Safe Use of Opioids in Hospitals
Responding to The Joint Commission Alert on Safe Use of Opioids in Hospitals Suzanne A Nesbit, PharmD, CPE Clinical Pharmacy Specialist, Pain Management The Johns Hopkins Hospital Objectives and Disclosures
More informationGuidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) Guidelines CH Lim, B Baizury, on behalf of Development Group Clinical Practice Guidelines Management of Major Depressive Disorder A. Introduction Major depressive
More informationPain and Addiction. Edward Jouney, DO Department of Psychiatry
Pain and Addiction Edward Jouney, DO Department of Psychiatry Case 43 year-old female with a history chronic lower back pain presents to your clinic ongoing care. She has experienced pain difficulties
More informationOpioid epidemic and PEHP
Opioid epidemic and PEHP Agenda Overview of opioid crisis Utah perspective PEHP: clinical interventions Impact of interventions Why are we here? In the 1990s, the medical establishment came to believe
More informationOpioid Review and MAT Clinic CDC Guidelines
1 Opioid Review and MAT Clinic CDC Guidelines January 10, 2018 Housekeeping Use chat feature to inform everyone who s at your clinic Click chat on Zoom option bar Chat Everyone the names of those who are
More informationMedication Management
Marina Treglia, AGPCNP BC April 4, 2019 Medication Management Identify patient criteria for risk mitigation in a medication management program at a multidisciplinary pain clinic Discuss opioid discontinuation
More informationFoundations of Safe and Effective Pain Management
Foundations of Safe and Effective Pain Management Evidence-based Education for Nurses, 2018 Module 1: The Multi-dimensional Nature of Pain Module 2: Pain Assessment and Documentation Module 3: Management
More informationRecommendation 1: Diagnosis of Generalized Anxiety Disorder (IΙΙ-2)
Final GAD RECOMMENDATIONS & EVIDENCE Recommendation 1: Diagnosis of Generalized Anxiety Disorder (IΙΙ-2) It is recommended for general practitioners and other Primary Health Care doctors to consider the
More informationBest Practices in Prescribing Opioids for Chronic Non-cancer Pain
Best Practices in Prescribing Opioids for Chronic Non-cancer Pain Disclosures S C O T T S T E I G E R, M D, F A C P, D A B A M A S S I S T A N T C L I N I C A L P R O F E S S O R D I V I S I O N O F G
More informationLisa Marzilli, PharmD, CDOE TOP 3 REASONS PEOPLE VISIT THEIR DOCTOR
Lisa Marzilli, PharmD, CDOE TOP 3 REASONS PEOPLE VISIT THEIR DOCTOR 1 1. Skin disorders, including cysts, acne, and dermatitis. 2. Joint disorders, including osteoarthritis. 3. Back problems. Source: Mayo
More informationAssessment and Management of Chronic Pain Guideline Summary
I CSI I NSTITUTE FOR CLINICAL S YSTEMS IMPROVEMENT Implementation Tool: Assessment and Management of Chronic Pain Guideline Summary Assessment Algorithm A = Annotation 1 Patient has pain 2 Critical first
More informationHOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain
Due to the high level of prescription drug use and abuse in Lake County, these guidelines have been developed to standardize prescribing habits and limit risk of unintended harm when prescribing opioid
More informationBest Practices in Prescribing Benzodiazepines. Michael Carlisle, DO Medical Director University Hospitals Geauga Medical Center
Best Practices in Prescribing Benzodiazepines Michael Carlisle, DO Medical Director University Hospitals Geauga Medical Center Objectives To review current practice guidelines in benzodiazepine prescribing
More informationSafe Opioid Prescribing Practices in the Elderly
Safe Opioid Prescribing Practices in the Elderly Masil George, MD Director, Geriatric Palliative Care Program Medical Director, Baptist Hospice This program has been funded under grant #U1QHP28723 No financial
More informationMonte H. Moore, MD. Idaho Physical Medicine and Rehabilitation. Meridian, ID
Monte H. Moore, MD Idaho Physical Medicine and Rehabilitation Meridian, ID Chronic pain brief review Opiates important things to know Factors in determining whether to use an opiate What to watch for if
More informationAcupuncture. Opioid Prescribing: Pitfalls for Occupational Medicine Physicians
Opioid Prescribing: Pitfalls for Occupational Medicine Physicians Presented by Scott Levy M.D. M.P.H. FACOEM Assistant Regional Medical Director, Occupational Health Services The Permanente Medical Group
More informationDENOMINATOR: All patients 18 and older prescribed opiates for longer than six weeks duration
Quality ID #414: Evaluation or Interview for Risk of Opioid Misuse National Quality Strategy Domain: Effective Clinical Care Meaningful Measure Area: Prevention and Treatment of Opioid and Substance Use
More informationThe Practical Aspects of Prescribing Opioids for Chronic Pain
The Practical Aspects of Prescribing Opioids for Chronic Pain - 2018 Lloyd Saberski, MD Internal medicine, Anesthesiology Pain management Faculty: Yale School of Medicine Department of Medicine Palliative
More informationSHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR OPIOID DEPENDENCE
SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR OPIOID DEPENDENCE INDICATION Naltrexone is a pure opiate antagonist licensed as an adjunctive prophylactic therapy in the maintenance
More informationMAT for Opioid Dependence. MAT and Pain Management. Epidemiology. Epidemiology. Factors Impacting Pain Perception 9/23/2014
MAT for Opioid Dependence Methadone maintenance treatment (MMT) Buprenorphine/naloxone (suboxone) Buprenorhine/naloxone (BupNX) Buprenorphine SL Parenteral naltrexone (P-ntx) Oral naltrexone (ntx) MAT
More informationHouse of Pain? A Standardized Approach to Chronic Pain In the Patient-Centered Medical Home. MAJ Meghan Raleigh, MD 17 MAR 2014
House of Pain? A Standardized Approach to Chronic Pain In the Patient-Centered Medical Home MAJ Meghan Raleigh, MD 17 MAR 2014 Make this house your own! Objectives Review key components in PCMH Identify
More informationASSESSING PATIENTS FOR TREATMENT WITH ER/LA OPIOID ANALGESIC THERAPY
ASSESSING PATIENTS FOR TREATMENT WITH ER/LA OPIOID ANALGESIC THERAPY Unit I Melvin Pohl, MD, FASAM Disclosure of Relevant Financial Relationships Content of Activity: ASAM Medical Scientific Conference
More informationUniversal Precautions and Opioid Risk. Assessment. Questions: How often do you screen your patients for risk of misuse when prescribing opioids?
Learning objectives 1. Identify the contribution of psychosocial and spiritual factors to pain 2. Incorporate strategies for identifying and mitigating opioid misuse 3. Incorporate non-pharmaceutical modalities
More informationOpioid use in older adults Is it a good idea? Regional Geriatric Rounds April 26, 2013
Opioid use in older adults Is it a good idea? Regional Geriatric Rounds April 26, 2013 Allen R. Huang, MDCM, FRCPC, FACP, AGSF Division of Geriatric Medicine allenhuang@toh.on.ca I have no conflict of
More informationAntidepressant Medication Therapy in Primary Care July 25, 2013
New York State Collaborative Care Initiative Antidepressant Medication Therapy in Primary Care July 25, 2013 http://uwaims.org Presenter Building on 25 years of Research and Practice in Integrated Mental
More informationAnalgesics: Management of Pain In the Elderly Handout Package
Analgesics: Management of Pain In the Elderly Handout Package Analgesics: Management of Pain in the Elderly Each patient or resident and their pain problem is unique. A complete assessment should be performed
More informationOpioids drive continued increase in drug overdose deaths
CDC: Drug overdose deaths increase for 11th consecutive year Opioids drive continued increase in drug overdose deaths Atlanta, GA, USA (February 20, 2013) - Drug overdose deaths increased for the 11th
More informationSUMMARY OF ARIZONA OPIOID PRESCRIBING GUIDELINES FOR THE TREATMENT OF CHRONIC NON-TERMINAL PAIN (CNTP)
9 SUMMARY OF ARIZONA OPIOID PRESCRIBING GUIDELINES FOR THE TREATMENT OF CHRONIC NON-TERMINAL PAIN (CNTP) SUMMARY OF ARIZONA OPIOID PRESCRIBING GUIDELINES FOR THE TREATMENT OF ACUTE PAIN NONOPIOID TREATMENTS
More informationPain management in Paediatric Palliative Care. Dr Jane Nakawesi 14 th August 2017
Pain management in Paediatric Palliative Care Dr Jane Nakawesi 14 th August 2017 Content Management of pain in children Non pharmacological Pharmacological Exit level outcomes The participants will: Know
More informationOpioids in the Management of Chronic Pain: An Overview
Opioids in the Management of Chronic Pain: An Overview Appropriate treatment of chronic pain may include both pharmacologic and non-pharmacologic modalities. The Board realizes that controlled substances,
More informationDuke Division of Physical Therapy, Department of Orthopaedics. Disclosures. Research funding from NIH, Foundation for PT (Magistro), and DoD
The Duplicity of Opioids How they Work, A Dubious History, and Person-Level Characteristics Chad Cook PhD, PT, MBA, FAAOMPT Program Director and Professor Duke Division of Physical Therapy, Department
More informationOxycodone use still increasing
Oxycodone use still increasing 14 BPJ Issue 36 In BPJ 24 (Nov, 2009) we reported that oxycodone use in New Zealand had been steadily rising. Latest pharmaceutical dispensing data suggest that oxycodone
More informationBest Practices for Prescribing Controlled Substances
Best Practices for Prescribing Controlled Substances Dr. Merrill Norton Pharm.D., D.Ph, ICCDP-D Clinical Associate Professor University of Georgia College of Pharmacy mernort@uga.edu Georgia Composite
More informationBenzodiazepines: risks, benefits or dependence
Benzodiazepines: risks, benefits or dependence A re-evaluation Council Report CR 59 January 1997 Royal College of Psychiatrists, London Due for review: January 2002 1 Contents A College Statement 3 Benefits
More informationKEY MESSAGES. It is often under-recognised and 30-50% of MDD cases in primary care and medical settings are not detected.
KEY MESSAGES Major depressive disorder (MDD) is a significant mental health problem that disrupts a person s mood and affects his psychosocial and occupational functioning. It is often under-recognised
More informationTreating Pain and Depression
Treating Pain and Depression Without Getting Depressed Joseph P, Arpaia, MD www.jparpaiamd.com More than 50% of patients with chronic pain also have clinically significant depression. Interestingly that
More informationKnock Out Opioid Abuse in New Jersey:
Knock Out Opioid Abuse in New Jersey: A Resource for Safer Prescribing GUIDELINE FOR PRESCRIBING OPIOIDS FOR CHRONIC PAIN IMPROVING PRACTICE THROUGH RECOMMENDATIONS CDC s Guideline for Prescribing Opioids
More informationMEDICATION ALGORITHM FOR ANXIETY DISORDERS
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences MEDICATION ALGORITHM FOR ANXIETY DISORDERS RYAN KIMMEL, MD MEDICAL DIRECTOR HOSPITAL PSYCHIATRY UNIVERSITY OF WASHINGTON
More informationCanadian Guideline for Opioids for Chronic Non-Cancer Pain. Speaker Disclosure. Objectives. Canadian Guideline for Opioids for Chronic Non-Cancer Pain
Canadian Guideline for Opioids for Chronic Non-Cancer Pain John Fraser Community Hospital Program New Glasgow November 1, 2017 This speaker has been asked to disclose to the audience any involvement with
More informationApproved Procedures for Prescribing and Monitoring Controlled Substances in South Carolina
Approved Procedures for Prescribing and Monitoring Controlled Substances in South Carolina Robert B. Hanlin, M.D., FAAFP Vice Chair, Medical Staff Affairs Greenville Health System Greenville, SC Disclosures
More informationPain and Addiction Challenges in 2013
Pain and Addiction Challenges in 2013 12JUN2013 1200 EDT IntNSA Webinar Series Funding for this webinar was made possible (in part) by (1H79T1022022) from SAMHSA. The views expressed in written webinar
More informationVirginia. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Virginia Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationPROVIDER BULLETIN. Published by Wyoming Workers Compensation Medical Case Management Unit October 21, 2015
Matthew H. Mead Governor State of Wyoming Department of Workforce Services DIVISION OF WORKERS COMPENSATION 1510 East Pershing Boulevard, South Wing Cheyenne, Wyoming 82002 http://www.wyomingworkforce.org
More informationScottish Blues- Benzodiazepines and Drug Related Deaths in Scotland
Scottish Blues- Benzodiazepines and Drug Related Deaths in Scotland EMCDDA Sep. 25 th 2014 Dr Saket Priyadarshi Associate Medical Director NHS Greater Glasgow and Clyde Vice-Chair, National Forum on Drug
More informationPsychiatric Consultant Role in Collaborative Care Sept 12, 2013
New York State Collaborative Care Initiative Psychiatric Consultant Role in Collaborative Care Sept 12, 2013 http://uwaims.org Presenter Building on 25 years of Research and Practice in Integrated Mental
More informationControlled Substance and Wellness Agreement
Controlled Substance and Wellness Agreement You and your provider have agreed on the use of controlled substance medications to treat your: We want to make sure you know how to manage your new prescription(s)
More informationPharmaceutical Interventions. Collaborative Model of Mental Health Care for Older Iowans Des Moines May 18, 2007
Pharmaceutical Interventions Collaborative Model of Mental Health Care for Older Iowans Des Moines May 18, 2007 Outline Overview Overview of initial workup and decisions in elderly depressed individual
More informationEvaluating Abuse, Misuse, Diversion, Overdose, Addiction, and Death in the Patient Population
Evaluating Abuse, Misuse, Diversion, Overdose, Addiction, and Death in the Patient Population ISCTM February 18, 2014 Beatrice Setnik, Ph.D. INC Research, Raleigh, NC Overview Prevalence of Rx drug misuse,
More informationVeteran s Integrative Pain (VIP) Center: A program for high risk patients on chronic opioids
Veteran s Integrative Pain (VIP) Center: A program for high risk patients on chronic opioids Hunter Holmes McGuire VA Richmond, VA Maggie Roma ANP-BC Clinic Administrative Coordinator Objectives Acknowledge
More informationMedication Assisted Treatment. Nicole Gastala, MD
Medication Assisted Treatment Nicole Gastala, MD Objectives Training Goals: To enhance the understanding of the participants in use of medication assisted therapy To increase the knowledge of participants
More informationRisk-Assessment Instruments for Pain Populations
Risk-Assessment Instruments for Pain Populations The Screener and Opioid Assessment for Patients with Pain (SOAPP) The SOAPP is a 14-item, self-report measure that is designed to assess the appropriateness
More informationRule Governing the Prescribing of Opioids for Pain
Rule Governing the Prescribing of Opioids for Pain 1.0 Authority This rule is adopted pursuant to Sections 14(e) and 11(e) of Act 75 (2013) and Sections 2(e) and 2a of Act 173 (2016). 2.0 Purpose This
More informationAcademic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD
Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse Pain, Pain Management and the Opioid Epidemic Symposium Jill M Williams, MD Professor Psychiatry Director, Division Addiction
More informationPatient-reported and interview-rated abuse-related outcomes
Patient-reported and interview-rated abuse-related outcomes Jennifer A. Haythornthwaite, Ph.D. Department of Psychiatry & Behavioral Sciences Johns Hopkins University School of Medicine October 2, 2009:
More informationBalance chronic pain management and responsible opioid prescribing. Michelle Bardack, M.D. Family & Community Medicine April 27, 2011
Balance chronic pain management and responsible opioid prescribing Michelle Bardack, M.D. Family & Community Medicine Overview Frame the dilemma Federation of State Medical Boards Discussion and questions
More informationOptimizing Suboxone in Opioid Addicts
Optimizing Suboxone in Opioid Addicts David Chim, D.O. Integrated Substance Abuse Programs Dept. of Psychiatry, UCLA K30 Translational Research Interest March 24, 2009 dchim@mednet.ucla.edu www.uclaisap.org
More informationClinical and Contextual Evidence Reviews
Clinical and Contextual Evidence Reviews Roger Chou, MD Professor of Medicine Oregon Health & Science University Director, Pacific Northwest Evidence-based Practice Center Purpose Summarize methods for
More informationThe Prescription Review Program and College Expectations. Dr. Rashmi Chadha MBChB MScCH CCFP MRCGP Dip. ABAM
The Prescription Review Program and College Expectations Dr. Rashmi Chadha MBChB MScCH CCFP MRCGP Dip. ABAM April 28, 2017 Disclosure Relationship with commercial interests: None Professional roles: Addictions
More information5/10/17. Back to Basics: The Role of Chronic Opioids for Chronic Pain. Thomas B. Gregory, PharmD, BCPS, FASPE, CPE. Disclosures. Nothing to disclose
Back to Basics: The Role of Chronic Opioids for Chronic Pain Thomas B. Gregory, PharmD, BCPS, FASPE, CPE Disclosures Nothing to disclose 1 Objectives Explain the role of opioids in chronic pain Describe
More informationSummary of Recommendations...3. PEG: A Three-Item Scale Assessing Pain (Appendix A) Chronic Pain Flow Sheet Acute Pain Flow Sheet...
Table of Contents Summary of Recommendations....3 PEG: A Three-Item Scale Assessing Pain (Appendix A)...12 Chronic Pain Flow Sheet...13 Acute Pain Flow Sheet...14 Pocket Guide: Tapering Opioids for Chronic
More informationD. Janene Holladay, M.D. Board Certifications: American Board of Anesthesiology American Board of Pain Medicine American Board of Addiction Medicine
D. Janene Holladay, M.D. Board Certifications: American Board of Anesthesiology American Board of Pain Medicine American Board of Addiction Medicine Financial Disclosure I have no relevant financial relationships
More informationNew Guidelines for Prescribing Opioids for Chronic Pain
New Guidelines for Prescribing Opioids for Chronic Pain Andrew Lowe, Pharm.D. CAPA Meeting October 6, 2016 THE EPIDEMIC Chronic Pain and Prescription Opioids 11% of Americans experience daily (chronic)
More informationChronic Disease Management for Pain: It CAN be done in primary care!
Chronic Disease Management for Pain: It CAN be done in primary care! Sondra Adkinson, PharmD, DAAPM, CPE Thomas B. Gregory, Pharm.D., BCPS, DASPE, CPE Chris Herndon, PharmD, BCPS, CPE Disclosures Adkinson:
More informationReadopt with amendment Med 502, effective (Document #11090), to read as follows:
Adopted Rules 11-2-16 1 Readopt with amendment Med 502, effective 5-3-16 (Document #11090), to read as follows: PART Med 502 OPIOID PRESCRIBING Med 502.01 Applicability. This part shall apply to the prescribing
More informationOpioid Prescribing for Acute Pain. Care for People 15 Years of Age and Older
Opioid Prescribing for Acute Pain Care for People 15 Years of Age and Older Summary This quality standard provides guidance on the appropriate prescribing, monitoring, and tapering of opioids to treat
More informationDr. Oslin receives grant support from the NIH, VA, and the Pennsylvania Department of Aging.
David W. Oslin, MD University of Pennsylvania Philadelphia VAMC Dr. Oslin receives grant support from the NIH, VA, and the Pennsylvania Department of Aging. Dr. Oslin is a consultant to the Hazelden Betty
More informationSubject: Pain Management (Page 1 of 7)
Subject: Pain Management (Page 1 of 7) Objectives: Managing pain and restoring function are basic goals in helping a patient with chronic non-cancer pain. Federal and state guidelines require that all
More informationManaging the Chronic Pain Patient. (and some stuff about opioids)
Managing the Chronic Pain Patient. (and some stuff about opioids) C. Patrick Carroll, M.D. Assistant Professor Johns Hopkins University School of Medicine Department of Psychiatry and Behavioral Sciences
More informationPALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST
PALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST TREATMENT IN ONCOLOGY Main treatment : surgery Neoadjuvant treatment : RT, CMT Adjuvant treatment : Tx micrometastatic disease -CMT,Targeted
More informationIPAP PTSD Algorithm -- Addenda
www.ipap.org/ptsd General Principles IPAP PTSD Algorithm -- Addenda I. Initial and repeated evaluations A. PTSD is common and often goes undiagnosed. Given the high prevalence of exposure to trauma (including
More informationNEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES
NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES GENERAL PRINCIPLES Neuropathic pain may be relieved in the majority of patients by multimodal management A careful history and examination are essential.
More informationAugust 4, 2013; Author: Ed Glick
American Cannabis Nurses Association Position Statement on Concurrent Cannabis and Opiate Use August 4, 2013; Author: Ed Glick Introduction The American Cannabis Nurses Association supports the monitored
More informationOPIOIDS AND NON-CANCER PAIN
Ch05.qxd 1/6/04 4:33 PM Page 77 CHAPTER 5 OPIOIDS AND NON-CANCER PAIN Background 78 Side-effects of opioids 78 Tolerance, physical dependence and addiction 79 Opioid-induced pain 79 Practical issues 80
More informationDRUGS THAT ACT IN THE CNS
DRUGS THAT ACT IN THE CNS Anxiolytic and Hypnotic Drugs Dr Karamallah S. Mahmood PhD Clinical Pharmacology 1 OTHER ANXIOLYTIC AGENTS/ A. Antidepressants Many antidepressants are effective in the treatment
More informationPrescription Drug Misuse/Abuse in Seniors. April Rovero Founder/Executive Director
Prescription Drug Misuse/Abuse in Seniors April Rovero Founder/Executive Director Deaths per 100,000 Population 30 25 Overdose Demographics Drug Poisoning Death Rates by Age: United States (2010) 20 15
More informationIntegrated Treatment of Co-morbid
Opportunities and Challenges in Integrated Treatment of Co-morbid Chronic Pain and Substance Use Disorders Mark Ilgen, PhD Ann Arbor VA, HSR&D Center of Excellence; Serious Mental Illness Treatment and
More informationAbout Your Pain Management
UW MEDICINE PATIENT EDUCATION About Your Pain Management Answers to common questions about opioids This handout explains the goals of managing pain with opioids, which are a type of prescription pain medicine.
More informationOpioids for Chronic Pain: COPYRIGHT. An Approach to Decision Making, Risk Management, & Monitoring
Opioids for Chronic Pain: An Approach to Decision Making, Risk Management, & Monitoring Marc Cohen MD Julia Lindenberg, MD Update in Internal Medicine 2016 Case n 51 y/o female with h/o bipolar disorder,
More informationThe Prescription Review Program and College Expectations. Dr. Rashmi Chadha MBChB MScCH CCFP MRCGP Dip. ABAM
The Prescription Review Program and College Expectations Dr. Rashmi Chadha MBChB MScCH CCFP MRCGP Dip. ABAM October 13, 2017 Disclosure Relationship with commercial interests: None Professional roles:
More informationPOLYSUBSTANCE USE IN THE TREATMENT OF OPIOID USE DISORDER WITH BUPRENORPHINE
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences POLYSUBSTANCE USE IN THE TREATMENT OF OPIOID USE DISORDER WITH BUPRENORPHINE MARK DUNCAN, MD November 8, 2018 SPEAKER
More informationUsing Benzodiazepines in Primary Care
Using Benzodiazepines in Primary Care Spencer A. Tighe MD, FRCPC Saturday, Feb. 16, 2008 Overview Historical context Drug information Indications Side effects Abuse vs. physical dependence Clinical practice
More informationAbout Your Pain Management
UW MEDICINE PATIENT EDUCATION About Your Pain Management Answers to common questions This handout outlines the goals of pain management treatment. It also reviews the guidelines that you are expected to
More informationTreating Anxiety Disorders. Adil Virani, BSc (Pharm), Pharm D, FCSHP
Treating Anxiety Disorders Adil Virani, BSc (Pharm), Pharm D, FCSHP Outline! Michelle s Case! Types of anxiety disorders! Goals of therapy! Treatment options and guidelines! Pharmacological options! Benzodiazepines
More informationM0BCore Safety Profile. Active substance: Bromazepam Pharmaceutical form(s)/strength: Tablets 6 mg FR/H/PSUR/0066/001 Date of FAR:
M0BCore Safety Profile Active substance: Bromazepam Pharmaceutical form(s)/strength: Tablets 6 mg P-RMS: FR/H/PSUR/0066/001 Date of FAR: 26.11.2013 4.3 Contraindications Bromazepam must not be administered
More informationManagement of high risk MMT patients. Meldon Kahan MD Methadone Prescribers Conference Toronto, Nov 15, 2013
Management of high risk MMT patients Meldon Kahan MD Methadone Prescribers Conference Toronto, Nov 15, 2013 CFPC CoI Templates: Slide 1 Faculty Disclosure Faculty: Meldon Kahan Relationships with commercial
More informationTHE PROS & CONS OF THE CDC GUIDELINES FOR SAFE OPIOID PRESCRIBING
THE PROS & CONS OF THE CDC GUIDELINES FOR SAFE OPIOID PRESCRIBING Ernest J Dole, PharmD, PhC, FASHP, BCPS Clinical Pharmacist University of New Mexico Hospitals And Clinical Associate Professor University
More informationDisclosures. The Problem. The Problem. The Problem. The Problem. Buprenorphine Use in Combined Chronic Pain and Opioid Addiction
Buprenorphine Use in Combined Chronic Pain and Opioid Addiction Sandra D. Comer, Ph.D. Disclosures Within the last 3 years, consulted for AstraZeneca, BioDelivery Sciences, Camarus, Clinilabs, Grunenthal,
More informationProposed Revision to Med (i)
Proposed Revision to Med 501.02 (i) I. Purpose This rule has been adopted to enable the Board to best protect public health and safety while providing a framework for licensees to effectively treat and
More informationTennessee. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Tennessee Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationPractical Tools for Psychologists Offering Pain Psychology Services: Dress Up as a Pain Psychologist and Get Treats
Practical Tools for Psychologists Offering Pain Psychology Services: Dress Up as a Pain Psychologist and Get Treats In a Nutshell Pain psychology is not a bad area in which to practice; Pain psychology
More informationIdaho DUR Board Meeting Minutes. Committee Member Present: David Agler, M.D., Dawn Berheim, Pharm.D., Perry Brown, M.D., Matthew Hyde, Pharm.D.
Idaho DUR Board Meeting Minutes Date: January 25, 2018 Time: 9am-12:00pm Location: Idaho Medicaid, 3232 Elder Street, Boise, Idaho, Conference Room D-West Moderator: David Agler, M.D. Committee Member
More informationMANAGEMENT OF VISCERAL PAIN
MANAGEMENT OF VISCERAL PAIN William D. Chey, MD, FACG Professor of Medicine University of Michigan 52 year old female with abdominal pain 5 year history of persistent right sided burning/sharp abdominal
More informationKurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center
Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Data from the National Vital Statistics System Mortality The age-adjusted rate of drug overdose deaths in the United States
More information